Life science deals: Picis, Horizon, Kalobios, and "medical devices" are hot
Just a reminder to check out David Hamilton’s writing over at VentureBeat LifeSciences. He covers the latest deals, from the massive $155 million in a company called Picis to deliver software to emergency room departments, to the Bay Area deals such as the $20 million in Kalobios, which develops antibody drugs, and $30 million in Horizon, which promotes drug safety. He’s covering deals as they happen. See his analysis here on the hot medical device sector, and why biotech has cooled.
Next Story: WiMAX company, Telsima, raises $25M in debt
Previous Story: San Francisco's tech sites down, amid power outage
About the Author, Matt Marshall
Matt launched VentureBeat in September of 2006, with the realization that no one else was covering the entrepreneurial and tech innovation scene with the velocity or depth that he was. Prior to founding VentureBeat, he covered venture capital for the San Jose Mercury News from 2001 to 2006. In 2002, Matt was awarded "Journalist of the Year" by the Northern California Society of Professional Journalists. Prior to working at the Merc, he was a correspondent for the Wall Street Journal in Bonn, Germany from 1995 to 1998, and a writer for the Washington Post in 1994. Matt holds a PhD in Government and an MA in German and European Studies from Georgetown University. In addition to VentureBeat, Matt is also the Executive Producer of DEMO, the leading launchpad event for emerging technologies.
VB Writers
Ben PopperEast Coast Editor
Dean TakahashiLead Writer, GamesBeat
Devindra HardawarNational Editor, MobileBeat Lead
Dylan TweneyExecutive Editor
ShoeEditor-in-Chief, GamesBeat
Heather KellySenior Editor
Jennifer Van GroveWriter
Jolie O'DellWriter
Matt MarshallFounder & Editor-in-Chief
Meghan KellyWriter
Sarah MitroffEditorial Assistant
Sean LudwigWriter
Sebastian HaleyReviews Editor, GamesBeat
Tom CheredarWriter
Ciara ByrneContributor
Julia PlevinContributor
Lindsey ComptonContributor
